GlassScriptPhysician profile
Paul J Davis
NPI 1518936731
$5,614.87
in general payments reported to CMS, 2019-2025
18 companies · $1,686 in 2025
The $1,686 reported for 2025 was more than what 99% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $404 · 2022: $710 · 2023: $1,161 · 2024: $1,654 · 2025: $1,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,500.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,518.99 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,141.87 | 2021-2025 | Xifaxan, Trulance, Relistor |
| Qol Medical, LLC | $670.42 | 2021-2025 | Sucraid, Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $478.67 | 2023-2025 | Entyvio, Gattex, Eohilia |
| Janssen Biotech, INC. | $443.15 | 2023-2025 | Tremfya, Stelara, Simponi Aria |
| Lilly USA, LLC | $357.90 | 2024-2025 | Omvoh |
| Regeneron Healthcare Solutions, INC. | $351.48 | 2022-2025 | Dupixent |
| Organon LLC | $222.25 | 2023-2025 | Renflexis, Hadlima |
| Braintree Laboratories, INC. | $143.25 | 2023-2025 | Sutab, Suflave |
| Boston Scientific Corporation | $69.66 | 2024-2025 | Watchman Access System |
| Merck Sharp & Dohme LLC | $57.86 | 2024 | Dificid |
| Redhill Biopharma INC. | $32.87 | 2021-2023 | Movantik, Aemcolo, Talicia |
| Sebela Pharmaceuticals INC. | $31.71 | 2022 | |
| Phathom Pharmaceuticals, INC. | $22.10 | 2024 | Voquezna |
| Axonics, INC. | $21.93 | 2024 | Axonics |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.89 | 2022 | |
| Intercept Pharmaceuticals, INC. | $17.53 | 2024 | |
| Acacia Pharma INC | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.